Clinical Trial Update: Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase 1/2 clinical trial evaluating the combination of temozolomide and vinorelbine in patients with recurrent brain metastas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Navelbine (vinorelbine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-01-18